<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECT: The authors sought to treat potentially catastrophic intracranial dural and deep <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> by using a multimodality endovascular approach </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Six patients aged 14 to 75 years presented with progressive symptoms of thrombotic intracranial venous occlusion </plain></SENT>
<SENT sid="2" pm="."><plain>Five presented with neurological deficits, and one patient had a progressive and intractable <z:hpo ids='HP_0002315'>headache</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> six had known risk factors for <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>: <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (two patients), <z:hpo ids='HP_0000100'>nephrotic syndrome</z:hpo> (one), <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (one), use of oral contraceptive pills (one), and puerperium (one) </plain></SENT>
<SENT sid="4" pm="."><plain>Four had combined dural and <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo>, whereas clot formation was limited to the dural venous sinuses in two patients </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent diagnostic cerebral arteriograms followed by transvenous catheterization and selective sinus and deep venous microcatheterization </plain></SENT>
<SENT sid="6" pm="."><plain>Urokinase was delivered at the proximal aspect of the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in dosages of 200,000 to 1,000,000 IU </plain></SENT>
<SENT sid="7" pm="."><plain>In two patients with <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> refractory to pharmacological thrombolytic treatment, mechanical wire microsnare maceration of the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> resulted in sinus patency </plain></SENT>
<SENT sid="8" pm="."><plain>Radiological studies obtained 24 hours after thrombolysis reconfirmed sinus/vein patency in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients' symptoms and neurological deficits improved, and no procedural complications ensued </plain></SENT>
<SENT sid="10" pm="."><plain>Follow-up periods ranged from 12 to 35 months, and <z:hpo ids='HP_0000001'>all</z:hpo> six patients remain free of any symptomatic venous reocclusion </plain></SENT>
<SENT sid="11" pm="."><plain>Factors including patients' age, preexisting medical conditions, and duration of symptoms had no statistical bearing on the outcome </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Patients with both dural and deep <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> often have a variable clinical course and an unpredictable neurological outcome </plain></SENT>
<SENT sid="13" pm="."><plain>With recent improvements in interventional techniques, endovascular therapy is warranted in symptomatic patients early in the disease course, prior to morbid and potentially fatal neurological deterioration </plain></SENT>
</text></document>